ODT
Odonate Therapeutics, Inc.
Director and 10% owner Aaron I. Davis bought $6.9M of Odonate Therapeutics, Inc.
Bought$6,863,428
$17.16Price
400,000Shares
+7%Stake
What ODT did for a copier
Prices for ODT after this filing aren't in yet.
Aaron I. Davis's record
6 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Dec 28. Filed Wed, Dec 30, 1:18 PM ET, during the session. Not investment advice.